Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

36.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
36.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.4K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

4.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.2K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

862
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
862
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

709
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
709
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

4.7K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pregnancy-related effect on elexacaftor, tezacaftor and ivacaftor pharmacokinetics in women with cystic fibrosis.

British journal of clinical pharmacology·2026
Same author

Persistence of proinsulin-only secretion in people with long-duration diabetes and minimal residual insulin secretion.

Diabetic medicine : a journal of the British Diabetic Association·2026
Same author

Pregnancy-Related Complications in Primary Aldosteronism: A European Survey.

Hypertension (Dallas, Tex. : 1979)·2026
Same author

HIF1-α induces mitochondrial fission in trophoblastic cells during early pregnancy and in preeclampsia.

iScience·2026
Same author

[Maternal serum markers profiles for Down syndrome: Review of comments and actionable recommendations].

Gynecologie, obstetrique, fertilite & senologie·2026
Same author

New PPARG Exons: Cell-Specific Expression of Their RNAs in the Human Placenta.

Cells·2026

Related Experiment Video

Updated: Mar 20, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.5K

[Pathophysiology of preeclampsia].

Edouard Lecarpentier1, Thierry Fournier2, Jean Guibourdenche1

  • 1Assistance publique-Hôpitaux de Paris, centre hospitalier universitaire Cochin Broca-Hôtel-Dieu, université Paris-Descartes, 75014 Paris, France; Inserm, UMR-S 1139, 75006 Paris, France; DHU risques et grossesse, 75014 Paris, France; Fondation PremUP, 75014 Paris, France.

Presse Medicale (Paris, France : 1983)
|May 25, 2016
PubMed
Summary

Preeclampsia, a pregnancy hypertension, stems from poor placental blood flow. Key placental factors, like PlGF/sFlt-1, contribute to maternal endothelial dysfunction in preeclampsia.

More Related Videos

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.6K
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K

Related Experiment Videos

Last Updated: Mar 20, 2026

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

1.5K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

16.6K
Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

12.0K

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Cardiovascular Physiology in Pregnancy

Background:

  • Preeclampsia is a serious hypertensive disorder unique to pregnancy.
  • It arises from abnormal blood flow between the mother and placenta (utero-placental circulation).
  • Placental dysfunction, marked by hypoperfusion and hypoxia/reoxygenation, is a central issue.

Purpose of the Study:

  • To elucidate the pathophysiological mechanisms underlying preeclampsia.
  • To highlight the role of specific trophoblastic factors in maternal endothelial dysfunction.

Main Methods:

  • Review of existing literature on preeclampsia pathophysiology.
  • Analysis of the role of placental factors in maternal circulation.

Main Results:

  • Abnormal utero-placental circulation leads to placental dysfunction.
  • Trophoblastic factors released from the placenta cause maternal endothelial dysfunction.
  • The placental growth factor (PlGF)/soluble fms-like tyrosine kinase-1 (sFlt-1) pair is critically involved.

Conclusions:

  • Utero-placental hypoperfusion and hypoxia drive placental dysfunction in preeclampsia.
  • Maternal endothelial dysfunction in preeclampsia is mediated by circulating trophoblastic factors.
  • The PlGF/sFlt-1 balance is a key player in preeclampsia pathogenesis.